– Program developments throughout 2022, and, to date in 2023, bring Grace Breeding closer to offering crop solutions to farmers aligned with environmental responsibility and reversing climate change –
REHOVOT, Israel, March 24, 2023 (GLOBE NEWSWIRE) — Grace Breeding Ltd. (the “Company” or “Grace Breeding”) (TASE: GRAC), a forward-thinking AgClimateTech company developing biological-based products to improve crop yield and vigor today reported full-year financial results for the period ending December 31, 2022.
“In 2022 just after taking the company public, and so far in 2023, we have made great strides to advance our NFT and WDS programs in parallel, bringing us closer towards our goal to sustainably address upstream and downstream solutions for the crop life cycle,” stated Assaf Dotan, Chief Executive Officer of Grace Breeding. “Most notably, with the support of our collaborators at the University of Londrina and Gaia AgroSolutions in Brazil, we are establishing significant momentum to advance our NFT bio-fertilizer. We are now closer to bringing our NFT technology to the commercial markets as a sustainable solution – both to reduce the detrimental effects of urea and improve corn growth in Brazil. This is key, as Brazil has just been forecasted as the number one corn exporter, surpassing, even the United States1.”
2022 and Recent Corporate and Program Developments
Mr. Dotan continued, “In preparation for commercialization, our goal this year will be to complete product registration for both our NFT bio-fertilizer and our WDS stress-tolerance enhancer. We will look to form further collaborations with strategic global entities supporting agricultural innovation such as we have done with our collaborators at Evolva Holding, a pioneer in natural molecules and industrial biotech. This is a key partnership that we recently announced since it will help to streamline our production process for producing our NFT.”
2023 Upcoming Goals and Milestones
2022 Financial Results
Grace Breeding Financial Statements
Consolidated Statement of Income (numbers in thousands, $000)
For the year ended December 31, 2021 |
For the year ended December 31, 2022 |
|
Revenues | 37 | 62 |
Cost of revenues | 29 | 78 |
Gain from fair value adjustments of biological assets |
30 | 17 |
Research & development | 377 | 1,482 |
Sales, General & Administrative |
525 | 1,718 |
Operating loss | (864) | (3,199) |
Financial expenses, net | (812) | (199) |
Total loss for the period | (1,676) | (3,398) |
Balance Sheet (numbers in thousands, $000)
For the year ended December 31, 2021 |
For the year ended December 31, 2022 |
|
Cash and cash equivalents | 225 | 1,059 |
Bank deposits | – | 1,040 |
Convertible loan | 113 | 106 |
Cash used for operating activities | 430 | 2439 |
About Grace Breeding’s NFT
Grace Breeding’s NFT works in combination with a natural, non-pathogenic bacteria enabling crops to naturally fix nitrogen and reducing the need for chemical fertilizers. As a result, the process reduces CO2 emissions and leads to a significantly lower environmental impact on soil and the ground water, while reducing synthetic nitrogen use by up to 50%. The global market for chemical nitrogen fertilizers reached a value of over $163.2 billion in 20212, but use of these fertilizers continues to come under great scrutiny with increased regulation due to their environmental impact on soil and ground water. As a result, sustainable alternatives that also are competitive for crop health are in demand by farmers and distributors. Grace Breeding’s NFT can be applied across a wide range of field crops including corn, wheat, soy and rice, and can be applied less frequently – once, during sowing versus three to four times during the season, which is otherwise the norm.
About Grace Breeding’s WDS
Grace Breeding’s WDS is an all-natural bio-stimulant that is a climate-tech solution, protecting a wide range of crops against abiotic climate stressors while improving yield and nutrient uptake. In field trials carried out by the company on industrial tomatoes in Israel, Grace Breeding’s WDS led to a 17% yield increase, despite stressful climate conditions.
About Grace Breeding
Grace Breeding is an AgClimateTech company focused on developing products that are biologically based and provide efficient and natural solutions for farmers and distributors. Grace Breeding aims to disrupt crop agriculture – by providing solutions for crop fertilization and climate stress relief and offering innovative products and solutions that reduce the environmental damage caused by synthetic fertilizers. Grace Breeding has an R&D center in Israel and in parallel the company is developing its products with several leading research and development centers around the world. For more information, visit https://www.gracebreeding.com.
References:
1Farmdoc Daily (“Will Brazil Emerge as the Number One Corn Exporting Nation?”; March 16, 2023)
2Fertilizer Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
Forward-Looking Statements
This press release contains forward-looking statements concerning our business operations and future plans. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. All forward-looking statements in this press release are made based on management’s current expectations which involve risks, uncertainties and other factors that could cause results to differ materially from those expressed in forward-looking statements. These statements involve a number of risks and uncertainties including, but not limited to, he preliminary nature of the Company’s business operations, the dependency on the success of future filed trials, the regulatory environment, the Company’s financial position and other risk factors. For a more detailed discussion of these and other risks that may cause actual results to differ from the forward-looking statements in this press release, please refer to our most recent annual report. The Company does not undertake any obligation to update forward-looking statements made herein.
Contacts
Grace Breeding Ltd.
Investors
Jeremy Feffer
LifeSci Advisors LLC
jfeffer@lifesciadvisors.com
Media
Inbar Kneller
ReBlonde Public Relations
inbar@reblonde.com
HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…
This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…
Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…
SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…
MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the…